Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.39 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31257785 | 0.92 | ALDH1A1 (0.43) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| SCHEMBL5179135 | 0.90 | ALDH1A1 (0.45) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| SCHEMBL27465326 | 0.89 | ALDH1A1 (0.50) | CYP1A2ALDH1A1HSD17B10HPGDERBB2 | |
| SCHEMBL2580469 | 0.87 | ALDH1A1 (0.44) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| SCHEMBL27834497 | 0.87 | ALDH1A1 (0.44) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| SCHEMBL2709997 | 0.87 | CYP1A2 (0.37) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| SCHEMBL5722785 | 0.86 | HPRT1 (0.41) | CYP1A2ALDH1A1HSD17B10HSD17B1HSD17B2 | |
| SCHEMBL2710690 | 0.85 | HSD17B1 (0.39) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| Fluoride SCHEMBL27626812 | 0.85 | ALDH1A1 (0.42) | CYP1A2ALDH1A1HSD17B10HPGDHSD17B1 | |
| SCHEMBL27656034 | 0.82 | HSD17B1 (0.53) | CYP1A2HSD17B1HSD17B2L3MBTL1DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2150517-B1 | CARBONYLATION PROCESS FOR THE PRODUCTION OF ACETIC ACID USING METAL-PINCER LIGAND CATALYSTS | BP CHEM INT LTD (GB) | 2014-02-26 | — | — | EP | disclosed |
| US-8198476-B2 | Carbonylation process for the production of acetic acid using metal-pincer ligand catalysts | BP CHEMICALS LIMITED (GB) | 2012-06-12 | — | — | US | disclosed |
| US-20100324332-A1 | CARBONYLATION PROCESS FOR THE PRODUCTION OF ACETIC ACID USING METAL-PINCER LIGAND CATALYSTS | BP CHEMICALS LIMITED (GB) | 2010-12-23 | — | — | US | disclosed |
| EP-2150517-A1 | CARBONYLATION PROCESS FOR THE PRODUCTION OF ACETIC ACID USING METAL-PINCER LIGAND CATALYSTS | BP Chemicals Limited (GB) | 2010-02-10 | — | — | EP | disclosed |
| WO-2008145976-A1 | CARBONYLATION PROCESS FOR THE PRODUCTION OF ACETIC ACID USING METAL-PINCER LIGAND CATALYSTS | BP CHEMICALS LIMITED (GB) | 2008-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324332-A1 | CARBONYLATION PROCESS FOR THE PRODUCTION OF ACETIC ACID USING METAL-PINCER LIGAND CATALYSTS | ACACA, PIN4, ACACB | CYP1A2 489/4885ALDH1A1 110/4885HSD17B10 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.